Combining Local and Regional Therapeutic Modalities to Treat Hepatic Malignancies

 

 Buy Article Permissions and Reprints

ABSTRACT

Hepatocellular carcinoma and metastatic colon cancer have proven to be challenging problems in oncology today. Currently multiple treatment options are available for treating patients with these diseases, and for this reason, a multimodality and multidisciplinary approach is needed to optimize the effectiveness of treatment. Local ablation techniques along with intra-arterial therapy may be complementary and therefore increase survival in patients being treated for hepatocellular carcinoma and metastatic colon cancer. With proper patient selection, further improvement in treatment outcomes can be achieved when these techniques are combined with surgical resection and multidrug systemic chemotherapy. Therefore, it is imperative that interventional radiologists work closely with our colleagues in other medical and surgical specialties to provide our patients with the best possible treatment options.

REFERENCES

• 1 Kitamoto M, Imagawa M, Hiroyasu Y et al.. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization.  AJR Am J Roentgenol. 2003;  181 997-1003
  PubMedGoogle Scholar
• 2 Maluccio M, Covey A, Gandhi R et al.. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.  J Vasc Interv Radiol. 2005;  16 955-961
  CrossrefPubMedGoogle Scholar
• 3 Koda M, Murawaki Y, Mitsuda A et al.. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.  Cancer. 2001;  92 1516-1524
  CrossrefPubMedGoogle Scholar
• 4 Kamada K, Kitamoto M, Aikata H et al.. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma.  Am J Surg. 2002;  184 284-290
  CrossrefPubMedGoogle Scholar
• 5 Yamakado K, Nakatsuka A, Ohmori S et al.. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology.  J Vasc Interv Radiol. 2002;  13 1225-1232
  CrossrefPubMedGoogle Scholar
• 6 Yamakado K, Nakatsuka A, Akeboshi M et al.. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: short-term recurrences and survival.  Oncol Rep. 2004;  11 105-109
  PubMedGoogle Scholar
• 7 Goldberg S N, Kamel I R, Kruskal J B et al.. Radiofrequency ablation of liver tumor: increased coagulation with adjuvant liposomal doxorubicin therapy.  AJR Am J Roentgenol. 2002;  179 93-101
  CrossrefPubMedGoogle Scholar
• 8 Llovet J M, Fuster J, Bruix J. Intention to treat analysis of surgical treatment for early hepatocellular carcinoma: resection vs. transplantation.  Hepatology. 1999;  30 1434-1440
  CrossrefPubMedGoogle Scholar
• 9 Harnois D M, Steers J, Andrews J C et al.. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma.  Liver Transpl Surg. 1999;  5 192-199
  CrossrefPubMedGoogle Scholar
• 10 Lau W, Ho S K, Yu S C et al.. Salvage surgery following downstaging of unresectable hepatocellular carcinoma.  Ann Surg. 2004;  240 299-305
  PubMedGoogle Scholar
• 11 Liu M, Uaje M, Al-Ghazi M S et al.. Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma.  Am Surg. 2004;  70 947-953
  PubMedGoogle Scholar
• 12 Geschwind J F, Salem R, Carr B I et al.. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.  Gastroenterology. 2004;  127(suppl 1) S194-S205
  CrossrefPubMedGoogle Scholar
• 13 Mathurin P, Raynard B, Dharancy S et al.. Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma.  Aliment Pharmacol Ther. 2003;  17 1247-1261
  CrossrefPubMedGoogle Scholar
• 14 Chan E SY, Chow P KH, Ta B C et al.. Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma.  Cochrane Database Syst Rev. 2004;  (4)
  PubMedGoogle Scholar
• 15 Mok K T, Wang B W, Lo G H et al.. Multimodality management of hepatocellular carcinoma larger than 10 cm.  J Am Coll Surg. 2003;  197 730-738
  CrossrefPubMedGoogle Scholar
• 16 Dohmen K, Shirahama M, Shigematsu H et al.. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.  Hepatogastroenterology. 2001;  48 1409-1415
  PubMedGoogle Scholar
• 17 Guo W J, Yu E K. The long-term efficacy of combined chemoembolization and local irradiation in the treatment of patients with large hepatocellular carcinoma.  Hepatogastroenterology. 2003;  50 500-503
  PubMedGoogle Scholar
• 18 Li B, Wang L, Li C et al.. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.  Am J Clin Oncol. 2003;  26 e92-e99
  CrossrefPubMedGoogle Scholar
• 19 Gray B, Van Hazel G, Hope M et al.. Randomized trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.  Ann Oncol. 2001;  12 1711-1720
  CrossrefPubMedGoogle Scholar
• 20 Taylor W E, Donohue J H, Gunderson L L et al.. The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer.  Ann Surg Oncol. 2002;  9 177-185
  CrossrefPubMedGoogle Scholar

Eric J HohenwalterM.D. 

Assistant Professor of Radiology, Vascular and Interventional Radiology

Department of Radiology, Medical College of Wisconsin, 9200 W. Wisconsin Avenue, Milwaukee, WI 53226